Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the fiel ...

Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...

Are you somebody who is focused on trying to lose weight, but for some reason can’t? There could be several reasons for ...

Hims and Hers is airing an ad about its copycat GLP-1 drugs during Sunday’s Super Bowl. Critics say it violates FDA rules.

Rocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

According to the journal JAMA Health Forum, prescription fills for Ozempic increased by more than 400% between January 2021 ...

As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...